Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.60 USD
Change Today 0.00 / 0.00%
Volume 0.0
ENUM On Other Exchanges
As of 8:10 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Arthur Tinkelenberg Ph.D.

Co-Founder, Chief Executive Officer, President and Director, Enumeral Biomedical Holdings, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 2 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Arthur H. Tinkelenberg, also known as Art, Ph.D., is a Co-Founder of Enumeral Biomedical Holdings, Inc. and has been its President and Chief Executive Officer since July 31, 2014. Prior to co-founding and leading Enumeral, Dr. Tinkelenberg was a Venture Partner of Ascent BioMedical Ventures (ABV). At Ascent Biomedical Ventures, he was responsible for originating and managing numerous biotechnology and medical device company investments from 2003 to 2009. Prior to ...

Read Full Background

Corporate Headquarters*

200 CambridgePark Drive
Cambridge, Massachusetts 02140

United States

Phone: 617-945-9146
Fax: --

Board Members Memberships*

Co-Founder, Chief Executive Officer, President and Director


Rockefeller University
Grinnell College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$174,609

Stock Options*

Exercisable Options12,504
Exercisable Options Value$625
Unexercisable Options87,496
Unexercisable Options Value$4,375
Total Value of Options$15,000
Total Number of Options300,000

Total Compensation*

Total Annual Cash Compensation$174,609
Total Short Term Compensation$174,609
Total Calculated Compensation$423,378
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENUM:US $0.60 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENUMERAL BIOMEDICAL HOLDINGS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at